Last reviewed · How we verify

NCT05412914

Remimazolam and Propofol on the Left Ventricular Strain During Anesthesia Induction for Non-cardiac Surgery

Status unknown Phase 4 Last updated 10 October 2023
What this trial tests

Phase 4 trial testing Remimazolam infusion in Surgical Procedure, Unspecified in 40 participants. Status unknown.

Timeline
26 January 2023
Primary endpoint
1 January 2024
1 January 2024

Quick facts

Lead sponsorKonkuk University Medical Center
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposediagnostic
Enrollment40
Start date26 January 2023
Primary completion1 January 2024
Estimated completion1 January 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Konkuk University Medical Center

Who can join

20 and older, any sex, with Surgical Procedure, Unspecified. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study to compare the impacts of remimazolam or propofol on the left ventricular global longitudinal strain (LV-GLS) during anesthesia induction for non-cardiac surgery. LV-GLS is analyzed by using speckle tracking technique of transthoracic echocardiography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Surgical Procedure, Unspecified

Currently open trials in the same condition.

Other Konkuk University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05412914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing